IPO registrations (S-1, F-1) · Registrants

Medicus Pharma Ltd.

SEC CIK
1997296 · filings on EDGAR ↗
Registration
Form F-1, S-1, first filed 2024-05-29, last 2025-11-19; 6 initial registrations, 9 amendments
Outcome
Final prospectus filed 2024-11-15; declared effective 2024-11-13
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
A6
Business address
300 CONSHOHOCKEN STATE RD., SUITE 200, W. Conshohocken, PA 19428
EIN
98-1778211
Ticker
MDCX, MDCXW (Nasdaq, Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Medicus Pharma Ltd. on the corporate pages

Offering terms

Final price
$4.64 per share (424B4 filed 2024-11-15, an initial public offering)
Shares sold
970,000
Gross proceeds
$4,500,800 before underwriting discounts and any over-allotment option
Listing
TSX under the symbol MDCX
Lead underwriters
Maxim Group
Syndicate
Brookline Capital Markets

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 29

FiledFormWhat it isName as filedEDGAR
2024-05-29F-1F-1 (foreign registration)Medicus Pharma Ltd.0001062993-24-011392 ↗
2024-07-15F-1/AF-1/A (amendment)Medicus Pharma Ltd.0001062993-24-013814 ↗
2024-08-09F-1/AF-1/A (amendment)Medicus Pharma Ltd.0001062993-24-014789 ↗
2024-08-23F-1/AF-1/A (amendment)Medicus Pharma Ltd.0001062993-24-015601 ↗
2024-09-23F-1/AF-1/A (amendment)Medicus Pharma Ltd.0001062993-24-016893 ↗
2024-09-26F-1/AF-1/A (amendment)Medicus Pharma Ltd.0001062993-24-017000 ↗
2024-10-01F-1/AF-1/A (amendment)Medicus Pharma Ltd.0001062993-24-017093 ↗
2024-10-15F-1/AF-1/A (amendment)Medicus Pharma Ltd.0001062993-24-017676 ↗
2024-10-29F-1/AF-1/A (amendment)Medicus Pharma Ltd.0001062993-24-018057 ↗
2024-10-31F-1/AF-1/A (amendment)Medicus Pharma Ltd.0001062993-24-018174 ↗
2024-11-13EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-24-003472 ↗
2024-11-15424B4424B4 (final prospectus)Medicus Pharma Ltd.0001062993-24-019175 ↗
2025-04-10EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-25-001062 ↗
2025-05-27S-1S-1 (registration)Medicus Pharma Ltd.0001062993-25-010333 ↗
2025-05-27S-1S-1 (registration)Medicus Pharma Ltd.0001062993-25-010394 ↗
2025-05-29EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-25-001778 ↗
2025-05-29EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-25-001780 ↗
2025-05-30424B4424B4 (final prospectus)Medicus Pharma Ltd.0001062993-25-010548 ↗
2025-09-29S-1S-1 (registration)Medicus Pharma Ltd.0001062993-25-015839 ↗
2025-09-29S-1S-1 (registration)Medicus Pharma Ltd.0001062993-25-015841 ↗
2025-11-14EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-25-003291 ↗
2025-11-14EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-25-003292 ↗
2025-11-19S-1S-1 (registration)Medicus Pharma Ltd.0001062993-25-016962 ↗
2025-12-04EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-25-003544 ↗
2025-12-31EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-26-000026 ↗
2026-02-04EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-26-000448 ↗
2026-03-27EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-26-000959 ↗
2026-03-27EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-26-000960 ↗
2026-03-27EFFECTEFFECT (declared effective)Medicus Pharma Ltd.9999999995-26-000961 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2024-10-31F-1/Aregistration statement880,000-TSX MDCX2primary document; shares headline, cover names 2document ↗
2024-11-15424B4final prospectus$4.64970,000$4,500,800TSX MDCX2primary document; price line, shares headline, proceeds computed, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
215 Capital TOGO PHL Fund I, LPTenPercentOwner12024
Ashton WilliamDirector62024–2026
Bokhari RazaDirector,OfficerChief Executive Officer72024–2026
Bonner Carolyn F.OfficerPresident; President and CFO62024–2026
Brennan Edward J.OfficerChief Scientific Officer62024–2026
Ciaruffoli Robert J.Director62024–2026
FISHMAN BARRYDirector62024–2026
Kaiser LarryDirector62024–2026
Lavelle Frank WDirector22024–2025
May Sara R.Director62024–2026
Mehmud FaisalOfficerChief Medical Officer72024–2026
Melani Kenneth R.TenPercentOwner32024–2025
Quinlan James P.OfficerChief Financial Officer32024–2025
Raju AjayDirector; Director,TenPercentOwner; TenPercentOwner52024–2026
Togo PHL Management LLCTenPercentOwner12024
VELOCITY FUND PARTNERS, LPTenPercentOwner22025
Smith Andrew AlasdairOfficerChief Operating Officer62025–2026
Rodgers Cathy McMorrisDirector42025–2026
MAHAFFY PATRICK JDirector42025–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2024-06-18Medicus Pharma Ltd.Other Health Care$11,017,500$11,017,500232
2023-10-13Medicus Pharma Ltd.Other Health Care$4,926,950$4,926,950681

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationMedicus Pharma, Inc.PAState business registriesname and state
Plan sponsorMEDICUS PHARMA, INC.PAForm 5500 (employee benefit plans)name and state
Form D issuerMedicus Pharma Ltd.Form D private offeringsCIK (EXACT)
SEC filerMedicus Pharma Ltd.SEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, PA first:

More with this interest.

In other datasets, the same topic (Health) in PA:

Interests: Pharmaceutical Preparations · Health